Vitekta

Ülke: Yeni Zelanda

Dil: İngilizce

Kaynak: Medsafe (Medicines Safety Authority)

Aktif bileşen:

Elvitegravir 85mg;  ;  ;  ;  

Mevcut itibaren:

Gilead Sciences (NZ)

INN (International Adı):

Elvitegravir 85 mg

Doz:

85 mg

Farmasötik formu:

Film coated tablet

Kompozisyon:

Active: Elvitegravir 85mg         Excipient: Croscarmellose sodium Hyprolose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Opadry green 85F91203 Sodium laurilsulfate

Reçete türü:

Prescription

Tarafından üretildi:

Gilead Sciences Inc

Terapötik endikasyonlar:

Indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults and adolescents when co-administered with a ritonavir-boosted protease inhibitor and other antiretroviral therapy.

Ürün özeti:

Package - Contents - Shelf Life: Bottle, plastic, HDPE with child resistant PE cap - 30 tablets - 24 months from date of manufacture stored at or below 25°C

Yetkilendirme tarihi:

2013-11-04